| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |